image

ACELYRIN - Company Information

ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    Agoura Hills, California, United States

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    100 - 249

  • icon
    Stock Symbol

    N/A

  • icon
    Website

    acelyrin.com

  • icon
    Type

    Private

icon

ACELYRIN Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by ACELYRIN

image

Nginx

thumbs_up

thumbs_down

Nginx is a web server which can also be used as a reverse proxy, load balancer, mail proxy...

See more technologies

ACELYRIN Employee Profiles

Are you looking for the decision-makers at ACELYRIN? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover ACELYRIN’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

ACELYRIN Competitors

Discover ACELYRIN alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

ALLIANCE SURGICAL CARE INC

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Alliance

  • icon
    Website

    N/A

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

OMID HAMID MD INC.

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Agoura Hills

  • icon
    Website

    N/A

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    N/A

image

Ivington CofE Primary School

  • icon
    Total Employees

    100 - 249

  • icon
    Location

    Leominster

  • icon
    Website

    ivington.hereford.sch.uk

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Parallax Capital Partners

  • icon
    Total Employees

    100 - 249

  • icon
    Location

    Laguna Hills

  • icon
    Website

    parallaxcap.com

  • icon
    Type

    Private

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Paulina Equities

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Chicago

  • icon
    Website

    N/A

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of ACELYRIN employees

Install Now
Company Logo

ACELYRIN News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are ACELYRIN latest news, alerts and updates.

ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the closing of its previously announced upsized initial public offering of 34,

Date Icon

9 May 2023

Acelyrin prices IPO at high end of range, increases share count again

Acelyrin (NASDAQ:SLRN) announced the pricing of its initial public offering. The late-stage biopharma company priced its IPO of 30M shares at $18 per share, at the high end of its proposed range. From the offering,

Date Icon

5 May 2023

ACELYRIN, INC. Announces Pricing of Upsized Initial Public Offering

ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the pricing of its upsized initial public offering of 30,

Date Icon

4 May 2023

Acelyrin Begins Rollout Of U.S. IPO Plan

ACELYRIN, Inc. has filed to raise development funding via a U.S. IPO. Click here for our take on the upcoming SLRN IPO and the prospects.

Date Icon

14 Apr 2023

Acelyrin files to go public in rare sign of biotech IPO

California biotech Acelyrin has filed to go public, a rare attempt to access the stock markets after a year of stock declines and cutbacks across the industry. Acelyrin was founded by veterans of Horizon Therapeutics in 2020,

Date Icon

13 Apr 2023

FAQs for ACELYRIN

Explore frequently asked questions about ACELYRIN’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is ACELYRIN's official website?

The official website of ACELYRIN is acelyrin.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at ACELYRIN?

faq icon

What industry is ACELYRIN in?

faq icon

What is ACELYRIN's tech stack?

faq icon

Where are ACELYRIN's headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2025 6sense